Cogstate Valuation Multiples

Cogstate is valued at $419M as of November 2026, a 5.8x revenue multiple. In the last 12 months, Cogstate revenue was $67M and Cogstate EBITDA was $20M.

Cogstate Overview

About Cogstate

Cogstate Ltd is a cognitive science company. The principal activity of the group is the Creation, validation, and commercialisation of digital brain health assessments; and the Design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials, Healthcare, and Administration. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.


Founded

1999

HQ

Australia

Employees

352

Financials (LTM)

Revenue: $67M
EBITDA: $20M

EV

$386M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Cogstate Financials

Cogstate reported last 12-month revenue of $67M and EBITDA of $20M.

In the same LTM period, Cogstate generated $41M in gross profit, $20M in EBITDA, and $13M in net income.

Revenue (LTM)


Cogstate P&L

In the most recent fiscal year, Cogstate reported revenue of $58M and EBITDA of $18M.

Cogstate is profitable as of last fiscal year, with gross margin of 58%, EBITDA margin of 31%, and net margin of 20%.

See analyst estimates for Cogstate
LTMLast FY202320242025202620272028
Revenue$67M$58M$42M$47M$55M
Gross Profit$41M$34M$23M$28M$32M
Gross Margin61%58%55%59%59%
EBITDA$20M$18M$7M$13M$17M
EBITDA Margin30%31%18%27%31%
EBIT Margin25%25%10%20%25%
Net Profit$13M$12M$5M$8M$11M
Net Margin20%20%11%17%20%
Net Debt-($34M)---

Financial data powered by Morningstar, Inc.

Cogstate Stock Performance

Cogstate has current market cap of $419M, and enterprise value of $386M.

Market Cap Evolution


Cogstate's stock price is $2.43.

Cogstate share price increased by 0.2% in the last 30 days, and by 44.2% in the last year.

Cogstate has an EPS (earnings per share) of $0.07.

See more trading valuation data for Cogstate
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$386M$419M0.4%0.2%10.0%44.2%$0.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Cogstate Valuation Multiples

Cogstate trades at 5.8x EV/Revenue multiple, and 19.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Cogstate

EV / Revenue (LTM)


Cogstate Financial Valuation Multiples

As of November 18, 2026, Cogstate has market cap of $419M and EV of $386M.

Cogstate has a P/E ratio of 31.8x.

LTMLast FY202320242025202620272028
EV/Revenue5.8x6.6x9.2x8.2x7.1x
EV/EBITDA19.0x21.0x51.8x29.8x22.4x
EV/EBIT22.8x26.2x91.5x40.1x27.8x
EV/Gross Profit9.4x11.4x16.7x13.9x11.9x
P/E31.8x35.2x93.0x53.8x38.0x
EV/FCF42.2x175.6xn/m62.7x72.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Cogstate Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Cogstate Margins & Growth Rates

Cogstate grew revenue by 30% and EBITDA by 28% in the last fiscal year.

In the most recent fiscal year, Cogstate reported gross margin of 58%, EBITDA margin of 31%, and net margin of 20%.

See estimated margins and future growth rates for Cogstate

Cogstate Margins

Last FY202420252026202720282029
Gross Margin58%59%59%59%
EBITDA Margin31%27%31%31%
EBIT Margin25%20%25%25%
Net Margin20%17%20%20%
FCF Margin4%13%10%15%

Cogstate Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth30%12%16%23%
Gross Profit Growth33%20%17%22%
EBITDA Growth28%74%33%22%
EBIT Growth33%128%44%23%
Net Profit Growth28%73%41%23%
FCF Growth695%426%(14%)85%

Data powered by FactSet, Inc. and Morningstar, Inc.

Cogstate Operational KPIs

Cogstate's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Cogstate's Rule of 40 is 54% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Cogstate's Rule of X is 89% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Cogstate
LTMLast FY202320242025202620272028
Rule of 4051%54%---
Bessemer Rule of X82%89%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue-0%0%0%0%
G&A Expenses to Revenue-2%8%6%4%
Opex to Revenue-33%45%38%34%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Cogstate Competitors

Cogstate competitors include TaiDoc Technology, InBody, Bayzed Health Group, Evolent Health, Veradigm, Yidu Tech, Echo IQ, SOPHiA Genetics, Definitive Healthcare and Ever Fortune.AI.

Most Cogstate public comparables operate across Health Data & Analytics and HealthTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
TaiDoc Technology$128M$56M1.9x-4.4x-
InBody$175M$33M1.7x1.4x8.7x5.9x
Bayzed Health Group$168M$18M2.4x-22.7x-
Evolent Health$1.9B($365M)0.7x0.5x(3.7x)10.0x
Veradigm$588M$54M0.9x0.9x10.2x7.1x
Yidu Tech$123M($4M)----
Echo IQ$62K($13M)3851.3x512.7x(19.1x)(20.9x)
SOPHiA Genetics$77M($65M)7.8x6.5x(9.3x)(17.0x)

This data is available for Pro users. Sign up to see all Cogstate competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Cogstate

When was Cogstate founded?Cogstate was founded in 1999.
Where is Cogstate headquartered?Cogstate is headquartered in Australia.
How many employees does Cogstate have?As of today, Cogstate has over 352 employees.
Is Cogstate publicly listed?Yes, Cogstate is a public company listed on Australian Securities Exchange.
What is the stock symbol of Cogstate?Cogstate trades under CGS ticker.
When did Cogstate go public?Cogstate went public in 2004.
Who are competitors of Cogstate?Cogstate main competitors include TaiDoc Technology, InBody, Bayzed Health Group, Evolent Health, Veradigm, Yidu Tech, Echo IQ, SOPHiA Genetics, Definitive Healthcare, Ever Fortune.AI.
What is the current market cap of Cogstate?Cogstate's current market cap is $419M.
What is the current revenue of Cogstate?Cogstate's last 12 months revenue is $67M.
What is the current revenue growth of Cogstate?Cogstate revenue growth (NTM/LTM) is 21%.
What is the current EV/Revenue multiple of Cogstate?Current revenue multiple of Cogstate is 5.8x.
What is the current EBITDA of Cogstate?Cogstate's last 12 months EBITDA is $20M.
What is Cogstate's EBITDA margin?Cogstate's last 12 months EBITDA margin is 30%.
What is the current EV/EBITDA multiple of Cogstate?Current EBITDA multiple of Cogstate is 19.0x.
What is the current FCF of Cogstate?Cogstate's last 12 months FCF is $9M.
What is Cogstate's FCF margin?Cogstate's last 12 months FCF margin is 14%.
What is the current EV/FCF multiple of Cogstate?Current FCF multiple of Cogstate is 42.2x.
How many companies Cogstate has acquired to date?Cogstate hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Cogstate has invested to date?Cogstate hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Cogstate

Lists including Cogstate

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial